This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
pms-Zopiclone (2015-09-24)
- Starting date:
- September 24, 2015
- Posting date:
- October 6, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-55146
Affected Products
pms-Zopiclone
Reason
These lots may contain oversized tablets exceeding the maximum recommended daily dose of 7.5 mg.
Depth of distribution
Wholesalers and pharmacies in Canada
Affected products
pms-Zopiclone
DIN, NPN, DIN-HIM
DIN 02240606
Dosage form
Tablet
Strength
7.5 mg
Lot or serial number
- 470882
- 470884
- 488194
- 488195
Companies
- Recalling Firm
-
Pharmascience Inc.
8580 L'Esplanade Ave.
Montreal
H2P 2R8
Quebec
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
8580 L'Esplanade Ave.
Montreal
H2P 2R8
Quebec
CANADA